학술논문
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
Document Type
article
Author
Jessica Justman; Timothy Skalland; Ayana Moore; Christopher I. Amos; Mark A. Marzinke; Sahar Z. Zangeneh; Colleen F. Kelley; Rebecca Singer; Stockton Mayer; Yael Hirsch-Moverman; Susanne Doblecki-Lewis; David Metzger; Elizabeth Barranco; Ken Ho; Ernesto T.A. Marques; Margaret Powers-Fletcher; Patricia J. Kissinger; Jason E. Farley; Carrie Knowlton; Magdalena E. Sobieszczyk; Shobha Swaminathan; Domonique Reed; Jean De Dieu Tapsoba; Lynda Emel; Ian Bell; Krista Yuhas; Leah Schrumpf; Laura Mkumba; Jontraye Davis; Jonathan Lucas; Estelle Piwowar-Manning; Shahnaz Ahmed
Source
Emerging Infectious Diseases, Vol 30, Iss 2, Pp 245-254 (2024)
Subject
Language
English
ISSN
1080-6040
1080-6059
1080-6059
Abstract
During January–August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.